CollPlant Biotechnologies Ltd of REHOVOT, L3, a company, filed a Form D exempt-offering notice with the SEC on 2017-11-03. The offering totals $5.0M, of which $2.0M was reported sold. Industry: Other Health Care.
Showing 25 of 43 people.
| Name | Role | Location |
|---|---|---|
| David Tsur | Director | Ness-Ziona, L3 |
| Oded Shoseyov | Executive Officer | Ness-Ziona, L3 |
| Shomrat Shurtz | Executive Officer | Ness-Ziona, L3 |
| Elan Penn | Director | Rehovot, L3 |
| Elan Penn | Related Person | Rehovot, L3 |
| Roger Dreiher Pomerantz | Director | Rehovot, L3 |
| Hugh Dreiher Evans | Director | Rehovot, L3 |
| Yehiel Tal | Director | Rehovot, L3 |
| Yehiel Tal | Executive Officer | Rehovot, L3 |
| Yehiel Tal | Related Person | Rehovot, L3 |
| Hadas Dreiher Horowitz | Executive Officer | Rehovot, L3 |
| Abraham Dreiher Havron | Director | Rehovot, L3 |
| Elana Gazal | Executive Officer | Rehovot, L3 |
| Alisa Dreiher Lask | Director | Rehovot, L3 |
| Philippe Bensimon | Executive Officer | Rehovot, L3 |
| Philippe Bensimon | Related Person | Rehovot, L3 |
| Eran Rotem | Executive Officer | Rehovot, L3 |
| Eran Rotem | Related Person | Rehovot, L3 |
| Joseph Dreiher Zarzewsky | Director | Rehovot, L3 |
| Oren Fahimipoor | Executive Officer | Rehovot, L3 |
| Oren Fahimipoor | Related Person | Rehovot, L3 |
| Elan Dreiher Penn | Director | Rehovot, L3 |
| Hugh Evans | Director | Rehovot, L3 |
| Hugh Evans | Related Person | Rehovot, L3 |
| ALISA LASK | Director | Rehovot, L3 |
| Filed | Form | Offering | Sold |
|---|---|---|---|
| 2026-07-20 | D | $10.4M | $10.4M |
| 2026-02-17 | D | $4.0M | $4.0M |
| 2025-06-04 | D | $3.9M | $3.9M |
| 2020-03-09 | D | $4.5M | $4.5M |
| 2019-09-10 | D | $3.5M | $3.5M |